Table 1.
Counts of participants with available information on maintenance immunosuppression by data source across the study time points and as fractions of sample alive with function
| Time after Transplantation | Alive with Graft Functiona | OPTN Forms Submittedb | Subsets of Sample Alive with Graft Function, Defined by Availability of Maintenance Immunosuppression Records in the Indicated Data Source(s) at the Study Time Point(s) (n [%])c
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OPTN | MR | CLM | OPTN and MR | OPTN and CLM | MR and CLM | Any | All | |||
| Discharge | 181 | 181 | 177 (97.8) | 137 (75.7) | 65 (35.9) | 137 (75.7) | 65 (35.9) | 50 (27.6) | 177 (97.8) | 50 (27.6) |
| 6 mo | 172 | 163 | 118 (68.6) | 143 (83.1) | 66 (38.4) | 116 (67.4) | 46 (26.7) | 57 (33.1) | 153 (89.0) | 45 (26.2) |
| 1 yr | 166 | 163 | 140 (84.3) | 159 (95.8) | 68 (41.0) | 138 (83.1) | 56 (33.7) | 66 (39.8) | 162 (97.6) | 55 (33.1) |
| All | 113 | 122 | 49 | 111 | 35 | 36 | 34 | |||
a
Counts from the total sample who received a transplant in 1998 through 2001 with Medicare as the primary insurer at the time of transplantation, regardless of the availability of immunosuppression information.
b
Counts of patients with any survey data submitted to the OPTN (not strictly immunosuppression records) at time point of interest.
c
Percentage of the total sample who were alive with function at study point of interest and had immunosuppression records in the indicated source.